RAEANN MEYER: Open Payments
NPI 1679658058 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 31 payments from 10 companies in 2025. Trend: 2023 $532 · 2024 $399 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $140 |
| Novo Nordisk Inc | 7 | $111 |
| Amgen Inc. | 5 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Organon LLC | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $15 |
Products named: VRAYLAR, EVENITY, Ozempic, Wegovy, UBRELVY, QULIPTA, SPRAVATO, CAPLYTA.
Industry payments across NE — which companies pay providers there.
